Sessions program & invited speakers

Program at a glance

CONGRESS CERTIFICIATE OF ATTENDANCE

An email will be sent to all congress delegates on Monday 23rd November containing a link to a congress survey. Once completed, you will receive your Certificate of Attendance within the following 24 hours.

Key lecture by George Q. Daley

MD PhD, Harvard Stem Cell Institute (Boston, US)

Session 1  : Mechanisms of reprogramming and genome stability

Chairman : Pierre Savatier

Manuel Serrano

Manuel Serrano

PhD, CNIO (Madrid, Spain)

Learn more

Robert Blelloch

Robert Blelloch

MD PhD, UCSF (San Francisco, US)

Learn more

Louise Laurent

Louise Laurent

MD PhD, UCSD (San Diego, US)

Learn More

Pierre Savatier

Pierre Savatier

MD PhD, Inserm (Lyon, FR)

Learn more

Session 2 : Regulation of ES / iPS cells diffrentiation

Chairman: Olivier Pourquié

Raul Mostovslaky

Raul Mostovslaky

MD PhD, Harvard Medical School (Boston, US)

Learn more

Daniel Aberdam

Daniel Aberdam

PhD, Inserm (Paris, FR)

Learn more

Olivier Pourquié

Olivier Pourquié

PhD, HSCI IGBMC (Strasbourg, FR)

Learn more

Session 3: Technical challenges

Chairman: Marc Peschanski

Paula M. Alves

Paula M. Alves

PhD, ITQB IBET (Oeiras, PT)

Learn more

Haiko Zimmermann

Haiko Zimmermann

PhD, Fraunhofer IBMT (Saint-Ingbert DE)

Learn More

Mathilde Girard

Mathilde Girard

PhD, I-Stem (Évry, FR)

Learn more

Amit Chandra

Amit Chandra

PhD, Loughborough University (UK)

Learn more

 

Session 4 : iPS disease modelling and disease research

Chairman: Jean-Marc Lemaitre

 

Chad Cowan

Chad Cowan

PhD, Harvard Stem Cell Institute (Boston, US)

Learn more

 

Ali Turhan

Ali Turhan

MD PhD, Université Paris Sud (Villejuif, FR)

Learn more

 

Jean-Marc Lemaitre

Jean-Marc Lemaitre

PhD, Inserm IRBM CHU-M (Montpellier, FR)

Learn more

 

 

Session 5: IPS models, from HTS plate-fom to therapeutic molecules

Chairman: Cécile Martinat

 

Lee Rubin

Lee Rubin

PhD, Harvard SCRB (Boston, US)

Learn more

 

Allison Ebert

Allison Ebert

PhD, MCW (Milawaukee, US)

Learn more

 

 

Chris Denning

Chris Denning

PhD, University of Nottingham (UK)

Learn more

 

 

Anselme Perrier

Anselme Perrier

PhD, I-Stem (Évry, France)

Learn more

 

Session 6: Tissue and & cell delivery, from basic research to clinical trials

Chairman: Annelise Bennaceur-Griscelli

 

Philippe Ménasché

Philippe Ménasché

MD, INSERM Université Paris Descartes (Paris, FR)

Learn more

 

Marc Turner

Marc Turner

PhD, CRM (Edinburgh)

Learn More

Peter Coffey

Peter Coffey

PhD, UCL (London, UK)

Learn more

Freidrich Metzger

Freidrich Metzger

PhD, Head of Discovery Rare Diseases Roche (Basel, SW)

Learn more

 

Register today and benefit from early bird fees for student, academic and industrial attendees.

Register now